Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 38

    1.

    Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.

    Ben Turkia H, Gonzalez DE, Barton NW, Zimran A, Kabra M, Lukina EA, Giraldo P, Kisinovsky I, Bavdekar A, Ben Dridi MF, Gupta N, Kishnani PS, Sureshkumar EK, Wang N, Crombez E, Bhirangi K, Mehta A.

    Am J Hematol. 2013 Mar;88(3):179-84. doi: 10.1002/ajh.23382. Epub 2013 Feb 9.

    PMID:
    23400823
    [PubMed - indexed for MEDLINE]
    2.

    Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.

    Gonzalez DE, Turkia HB, Lukina EA, Kisinovsky I, Dridi MF, Elstein D, Zahrieh D, Crombez E, Bhirangi K, Barton NW, Zimran A.

    Am J Hematol. 2013 Mar;88(3):166-71. doi: 10.1002/ajh.23381. Epub 2013 Feb 6.

    PMID:
    23386328
    [PubMed - indexed for MEDLINE]
    3.

    Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase.

    Zimran A, Pastores GM, Tylki-Szymanska A, Hughes DA, Elstein D, Mardach R, Eng C, Smith L, Heisel-Kurth M, Charrow J, Harmatz P, Fernhoff P, Rhead W, Longo N, Giraldo P, Ruiz JA, Zahrieh D, Crombez E, Grabowski GA.

    Am J Hematol. 2013 Mar;88(3):172-8. doi: 10.1002/ajh.23383. Epub 2013 Jan 22.

    PMID:
    23339116
    [PubMed - indexed for MEDLINE]
    4.

    Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones.

    Yang C, Rahimpour S, Lu J, Pacak K, Ikejiri B, Brady RO, Zhuang Z.

    Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):966-71. doi: 10.1073/pnas.1221046110. Epub 2012 Dec 31.

    PMID:
    23277556
    [PubMed - indexed for MEDLINE]
    5.

    KIR genes and HLA class I ligands in Gaucher disease.

    Vairo F, Portela P, Salim PH, Jobim M, Netto C, Dorneles A, Mittlestadt S, Jobim LF, Schwartz IV.

    Gene. 2013 Mar 1;516(1):53-7. doi: 10.1016/j.gene.2012.12.014. Epub 2012 Dec 21.

    PMID:
    23266622
    [PubMed - indexed for MEDLINE]
    6.

    Jaws features in Type 1 Gaucher disease.

    Zeevi I, Anavi Y, Kaplan I, Zadik Y.

    J Oral Maxillofac Surg. 2013 Apr;71(4):694-701. doi: 10.1016/j.joms.2012.09.020. Epub 2012 Dec 21. Review.

    PMID:
    23265852
    [PubMed - indexed for MEDLINE]
    7.

    Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease.

    Franco M, Collec E, Connes P, van den Akker E, Billette de Villemeur T, Belmatoug N, von Lindern M, Ameziane N, Hermine O, Colin Y, Le Van Kim C, Mignot C.

    Blood. 2013 Jan 17;121(3):546-55. doi: 10.1182/blood-2012-07-442467. Epub 2012 Dec 3.

    PMID:
    23212518
    [PubMed - indexed for MEDLINE]
    8.

    Gaucher disease: insights from a rare Mendelian disorder.

    Sidransky E.

    Discov Med. 2012 Oct;14(77):273-81. Review.

    PMID:
    23114583
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Haematological manifestations and complications of Gaucher disease.

    Hughes DA, Pastores GM.

    Curr Opin Hematol. 2013 Jan;20(1):41-7. doi: 10.1097/MOH.0b013e32835a9148. Review.

    PMID:
    23108221
    [PubMed - indexed for MEDLINE]
    10.

    Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease.

    Panicker LM, Miller D, Park TS, Patel B, Azevedo JL, Awad O, Masood MA, Veenstra TD, Goldin E, Stubblefield BK, Tayebi N, Polumuri SK, Vogel SN, Sidransky E, Zambidis ET, Feldman RA.

    Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18054-9. doi: 10.1073/pnas.1207889109. Epub 2012 Oct 15.

    PMID:
    23071332
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Successful desensitization to imiglucerase of an adult patient diagnosed with type I Gaucher disease.

    Erdoğdu D, Gelincik A, Canbaz B, Colakoğlu B, Büyüköztürk S, Tanakol R.

    Int Arch Allergy Immunol. 2013;160(2):215-7. doi: 10.1159/000339754. Epub 2012 Sep 25.

    PMID:
    23018845
    [PubMed - indexed for MEDLINE]
    12.

    Induction of osteoclastogenesis in an in vitro model of Gaucher disease is mediated by T cells via TNF-α.

    Mucci JM, Scian R, De Francesco PN, García FS, Ceci R, Fossati CA, Delpino MV, Rozenfeld PA.

    Gene. 2012 Nov 1;509(1):51-9. doi: 10.1016/j.gene.2012.07.071. Epub 2012 Aug 6.

    PMID:
    23010424
    [PubMed - indexed for MEDLINE]
    13.

    Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging.

    Argyriou A, Dermentzaki G, Papasilekas T, Moraitou M, Stamboulis E, Vekrellis K, Michelakakis H, Stefanis L.

    Neurosci Lett. 2012 Oct 24;528(2):205-9. doi: 10.1016/j.neulet.2012.08.069. Epub 2012 Sep 7.

    PMID:
    22981881
    [PubMed - indexed for MEDLINE]
    14.

    In brief: Taliglucerase (Elelyso) for Gaucher disease.

    [No authors listed]

    Med Lett Drugs Ther. 2012 Jul 9;54(1394):56. No abstract available.

    PMID:
    22966489
    [PubMed - indexed for MEDLINE]
    15.

    Minimal disease activity in Gaucher disease: criteria for definition.

    Di Rocco M, Andria G, Bembi B, Carubbi F, Giona F, Giuffrida G, Linari S, Sibilio M, Spina V, Cappellini MD.

    Mol Genet Metab. 2012 Nov;107(3):521-5. doi: 10.1016/j.ymgme.2012.08.009. Epub 2012 Aug 17.

    PMID:
    22954583
    [PubMed - indexed for MEDLINE]
    16.

    Analysis of the pre-retinal opacities in Gaucher Disease using spectral domain optical coherent tomography.

    Sheck LH, Wilson CJ, Vincent AL.

    Ophthalmic Genet. 2012 Dec;33(4):253-6. doi: 10.3109/13816810.2012.716489. Epub 2012 Sep 6.

    PMID:
    22950450
    [PubMed - indexed for MEDLINE]
    17.

    Disease state awareness in Gaucher disease: a Q&A expert roundtable discussion.

    Mistry PK, Weinthal JA, Weinreb NJ.

    Clin Adv Hematol Oncol. 2012 Jun;10(6 Suppl 8):1-16.

    PMID:
    22895100
    [PubMed - indexed for MEDLINE]
    18.

    Screening of high-risk Gaucher disease patients in Brazil using miniaturized dried blood spots and leukocyte techniques.

    Goldim MP, Garcia Cda S, de Castilhos CD, Daitx VV, Mezzalira J, Breier AC, Cé J, Mello A, Andrade CV, Sartori N, Coelho JC.

    Gene. 2012 Oct 25;508(2):197-8. doi: 10.1016/j.gene.2012.07.011. Epub 2012 Aug 3.

    PMID:
    22884741
    [PubMed - indexed for MEDLINE]
    19.

    South African guidelines for the management of Gaucher disease, 2011.

    Lysosomal Storage Disorder Medical Advisory Board, Bhengu L, Davidson A, du Toit P, Gerntholtz T, Govendragaloo K, Heitner R, Henderson B, Mubaiwa L, Varughese S.

    S Afr Med J. 2012 Jun 20;102(8):697-702.

    PMID:
    22831951
    [PubMed - indexed for MEDLINE]
    20.

    Hematopoietic stem cell transplantation for Gaucher disease.

    Somaraju UR, Tadepalli K.

    Cochrane Database Syst Rev. 2012 Jul 11;7:CD006974. doi: 10.1002/14651858.CD006974.pub3. Review.

    PMID:
    22786501
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk